Drugdiscovery >> Drugs >> News
8072
Views
Takeda's schizophrenia drug lurasidone approved in Swiss - drugdiscovery.com
Takeda's schizophrenia drug lurasidone approved in Swiss - drugdiscovery.com


This is the first approval in Europe for lurasidone, which is already marketed as Latuda for schizophrenia and bipolar depression in the US and Canada.
Read More >>


Tags: lurasidone, latuda, drug, schizophrenia, bipoloar disorder, Swiss, approval, Europe - August 14, 2013
Related Articles
6002
Views
The first approved treatment for negative symptoms in schizophrenia to be launched in 2016 The first approved treatment for negative symptoms in schizophrenia to be launched in 2016
Roche/Chugai's glycine transporter-1 inhibitor bitopertin is poised to be the first-in-class agent for the treatment of negative symptoms in schizophrenia. The launch in the United States and Europe ( Read More >>

Tags: bitopertin, Roche, negative symptoms in schizophrenia, schizophrenia, symptoms, negative, new drug, new therapy

10283
Views
Another Sanofi MS drug approved in EU Another Sanofi MS drug approved in EU
After Aubagio, Lemtrada - another Sanofi’s drug for treatment of multiple sclerosis has been approved by the European Commission. Read More >>

Tags: multiple sclerosis, Europe, new drug, Aubagio, Lemtrada

14560
Views
How Drugs are Developed and Approved How Drugs are Developed and Approved
In the United States, all medications except natural remedies and supplements, must go through an approval process before they can be made available to people. The Food and Drug Administration (FDA) i Read More >>

Tags: FDA, CDER, drug safety

13231
Views
Bayer’s new hypertension drug to be approved by FDA Bayer’s new hypertension drug to be approved by FDA
The new drug worked well in clinical trials and is recommended for approval but at lower doses than those proposed by the company. Read More >>

Tags: Bayer, new drug, hypertension, pulmonary hypertension

11880
Views
New drug for treating myeloma approved in Europe New drug for treating myeloma approved in Europe
The European Commission has granted approval for Celgene’s drug pomalidomide for the treatment of relapsed and refractory multiple myeloma, in combination with dexamethasone. The marketing name of Read More >>

Tags: Celgene, pomalidomide, multiple myeloma,Imnovid,the European Commission approval

7373
Views
Astellas’ diarrhea drug - Irribow approved in Japan Astellas’ diarrhea drug - Irribow approved in Japan
Astellas Pharma announced the approval of the additional formulation of Irribow OD Tablets for treatment of diarrhea-predominant irritable bowel syndrome in Japan. Read More >>

Tags: Irribow, Astellas, diarrhea, irritable bowel syndrome, approval

13077
Views
New  erectile dysfunction drug approved  in Ireland and the Netherlands New erectile dysfunction drug approved in Ireland and the Netherlands
Apricus Biosciences has been granted marketing authorization for Vitaros(R) indicated for the treatment of patients with erectile dysfunction. It is already approved in Sweden and the United Kingdom Read More >>

Tags: Vitaros, Apricus Biosciences, erectile dysfunction, approval, marketing authorization

7262
Views
Novartis’ COPD treatments approved in EU and Japan Novartis’ COPD treatments approved in EU and Japan
Ultibro Breezhaler has been approved by the European Commission as a maintenance bronchodilator treatment in adult patients with chronic obstructive pulmonary disease (COPD). Ultibro Inhalation Capsul Read More >>

Tags: Ultibro, COPD, drug, Novartis, approval, EU, Japan

11797
Views
Teva’s drug for treating neutropenia approved in EU Teva’s drug for treating neutropenia approved in EU
Teva got EU market authorization for the drug Lonquex (lipegfilgrastim) , which is used for reduction of the duration of neutropenia and the incidence of febrile neutropenia in patients undergoing c Read More >>

Tags: Teva, lonquex, Neulasta, EMA, EU, approval,febrile neutropenia, neutropenia, cancer patients, patients undergoing chemotherapy

5832
Views
Bayer's hypertension drug Adempas approved in Canada Bayer's hypertension drug Adempas approved in Canada
The Health Canada has approved the drug Adempas (riociguat) for the treatment of a severe, progressive and life-threatening condition of the heart and lungs, chronic thromboembolic pulmonary hypertens Read More >>

Tags: Adempas, riociguat, Bayer, hypertension drug, thromboembolic, pulmonary hypertension, Canada, approval

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013